etkin elifoğlu
@etkiinss
aütf’22. / Ankara Etlik City Hospital / Cardiology resident
It has been an extraordinary experience for me to present here. I would like to express my sincere gratitude to my mentors and to the entire ESC Heart Failure family for their invaluable support and contributions. #HeartFailure2025 #hfa2025
SGLT2i are supported with a class I recommendation in global guidelines for HFpEF Guidelines regarding MRAs are being revisited / updated based on the recent #FINEARTSHF trial
🚨 Finerenone Approved by US FDA in HF based on #FINEARTSHF Finerenone (Kerendia) is a non-steroidal MRA indicated to reduce the risk of CV death, hospitalization for HF, & urgent HF visits in adult patients with HF with LVEF>= 40% bayer.com/media/en-us/us…
Avrasya Kalp Yetersizliği Derneği olarak başta @DrServetAltay olmak üzere tüm editoryal ekibi kutluyoruz…
🗞️ DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure #DIGIT_HF Baseline characteristics compared to recent randomized controlled #HF trials @ESC_Journals @GiuseppeGalati_ @AmrAbdin10 @HanCardiomd @JBauersachsMD @BiykemB bit.ly/3HJQks3
Switching from sMRA to Finerenone in patients with CKD and Type 2 diabetes: Patients in treatment with spironolactone/eplerenone showed a significant reduction in serum potassium at 3 months when switched to finerenone. No changes in serum creatinine
More than 50% reduction in uacr with combo and about 30% with each component that is empagliflozin and finerenone. Time to consider simultaneous initiation of combination therapy in ckd and t2d as in hfref and stage 2 hypertension.
🔥 #CONFIDENCE in @NEJM Simultaneous initiation of #SGLT2i + #nsMRA safely and rapidly delivers in patients with CKD & T2D A new age of combination therapies has arrived in #CKM care #ERA25 nejm.org/doi/full/10.10…
HFA 2025’te sunulan “Hottest Trials” özetleri TKD KY Çalışma Grubu bülteninde! ❤️🔥 #HeartFailure2025 @TKDResmi @ozlemyt @DrHKKKY @tugceinci88 @seldamurat_dr @MDuyguinan @CetinAlak @yildiz__ufuk @ziya_sener @etkiinss @ofkarus 🫀 tkd.org.tr/KYBulteni/?say…
#GDMT has now arrived for #HFpEF #SGLT2i (class I) and #nsMRA (class IIa) recommendations in initial global guidelines jstage.jst.go.jp/article/circj/… #HeartFailure2025
Prof @WilfriedMullens shared 6 key decongestive rules to overcome diuretic resistance: 1️⃣ Start diuretics without delay 2️⃣ Right dose of IV bolus, & combination therapy 3️⃣ Early response evaluation 4️⃣ Natriuresis-guided approach 5️⃣ Don’t stop until dry, while optimize #GDMT 6️⃣…
Professor Dr Biykem Bozkurt was my mentor during the HFA Career Café event. It was a great honour for me to meet you. @BiykemB #HeartFailure2025
#GenelGrev #çağlayan Dikta rejimi beka sorunudur. Türk halkı tek adam ve partisinden büyüktür.
Yıllarca Z kuşağı diye diye burnumuzla kakaladık, şimdi bize cesaret dersi veriyorlar. Hele en önde yürüyüp polisin karşısında dik duran kız öğrenciler... Hayran olmamak elde değil, adil ve onurlu bir yaşam için bizim yapamadığımızı yapıyorlar 💪🇹🇷 #TehlikeGeliyor #GenelGrev
Hypertrophic cardiomyopathy. LVOT gradient- 170 mmHg. M, 18 y.o
✨We can obtain so much information from a single Transthoracic Echo in patients with cardiac amyloidosis 🌟 🎯Be aware of clinical and #echofirst red flags for an early diagnosis 💛 🎯Don’t be afraid to communicate/report your suspicion to foster further investigation,…
🔴Right ventricular function: Echocardiographic Evaluation ⤵️♥️ 🔹onlinelibrary.wiley.com/doi/full/10.10… #Diagnosis #Cardiology #POCUS #Echocardiogram #RightVentricle #RightVentricular #RVDysfunction #Measurements #Criteria #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology